Legal Representation
Attorney
Keith Barritt
USPTO Deadlines
Application History
47 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Nov 9, 2020 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Nov 9, 2020 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Mar 26, 2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 25, 2020 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Mar 23, 2020 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Mar 23, 2020 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Sep 13, 2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Sep 12, 2019 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Sep 12, 2019 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Sep 10, 2019 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Sep 10, 2019 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Aug 15, 2019 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | Loading... |
| Mar 15, 2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 13, 2019 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Mar 13, 2019 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Mar 13, 2019 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Sep 13, 2018 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Sep 11, 2018 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Sep 11, 2018 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Sep 11, 2018 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jun 29, 2018 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Jun 29, 2018 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| May 23, 2018 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| May 23, 2018 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Mar 28, 2018 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 26, 2018 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Mar 26, 2018 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Mar 26, 2018 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 3, 2017 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Aug 8, 2017 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Aug 8, 2017 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jul 19, 2017 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jun 28, 2017 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jun 22, 2017 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jun 22, 2017 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jun 22, 2017 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Jun 22, 2017 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Jun 7, 2017 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jun 6, 2017 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jun 6, 2017 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Dec 7, 2016 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Dec 7, 2016 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Dec 7, 2016 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Dec 6, 2016 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Nov 2, 2016 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| Sep 1, 2016 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Aug 30, 2016 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Vaccines; pharmaceutical preparations for the treatment and/or prevention of infectious diseases; medicines for the treatment and/or prevention of infectious diseases; biological preparations for the prevention and/or treatment of infectious diseases; biotherapeutic pharmaceuticals for the prevention and/or treatment of infectious diseases; biosimilars in the nature of therapeutic agents, namely, nucleic acid therapeutics for the prevention and/or treatment of infectious diseases; vaccine adjuvants
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"VACCINES"